A phase III study assessing Alpha1H for bladder cancer
Latest Information Update: 09 Aug 2022
At a glance
- Drugs Alpha lactalbumin oleic acid (Primary)
- Indications Bladder cancer
- Focus Registrational; Therapeutic Use
- Sponsors Hamlet Pharma AB
- 02 Aug 2022 According to a Hamlet Pharma AB media release, the trial will include addition of a second treatment round after the completion of the first round of treatment.
- 02 Aug 2022 Status changed from planning to recruiting, according to a Hamlet Pharma AB media release.
- 28 Oct 2020 New trial record